CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 159 filers reported holding CASTLE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,948,503 | +23.1% | 648,224 | 0.0% | 0.23% | +29.1% |
| Q2 2023 | $8,893,633 | -39.6% | 648,224 | 0.0% | 0.18% | -40.5% |
| Q1 2023 | $14,727,649 | -12.6% | 648,224 | -9.5% | 0.29% | -13.8% |
| Q4 2022 | $16,860,384 | +3.6% | 716,244 | +14.7% | 0.34% | -2.3% |
| Q3 2022 | $16,279,000 | +15.6% | 624,196 | -2.7% | 0.35% | +23.8% |
| Q2 2022 | $14,081,000 | -29.4% | 641,512 | +44.4% | 0.28% | -14.3% |
| Q1 2022 | $19,933,000 | +4.6% | 444,342 | 0.0% | 0.33% | +15.8% |
| Q4 2021 | $19,049,000 | -16.7% | 444,342 | +29.2% | 0.28% | -19.1% |
| Q3 2021 | $22,864,000 | -9.3% | 343,817 | 0.0% | 0.35% | -7.4% |
| Q2 2021 | $25,212,000 | +38.5% | 343,817 | +29.3% | 0.38% | +29.8% |
| Q1 2021 | $18,202,000 | +56.0% | 265,877 | +53.0% | 0.29% | +47.5% |
| Q4 2020 | $11,668,000 | +41.4% | 173,762 | +8.3% | 0.20% | +22.2% |
| Q3 2020 | $8,251,000 | +61.6% | 160,375 | +18.4% | 0.16% | +57.3% |
| Q2 2020 | $5,106,000 | – | 135,480 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |